Features | Partner Sites | Information | LinkXpress
Sign In

Agreement to Expand Distribution for MR Volumetric Brain Atrophy Software

By Medimaging International staff writers
Posted on 10 Feb 2014
New software is the only US Food and Drug Administration (FDA)-approved medical device capable of automatically detecting and quantifying atrophy in the human brain and provides accurate, and fully automated magnetic resonance imaging (MRI) post-processing capabilities to the physician’s mobile device or desktop.

This provides radiologists, neuroadiologists, and clinical researchers with a convenient and cost-effective way to quantify atrophy of brain structures to help identify a range of brain disorders, including conditions such as Alzheimer’s disease, epilepsy and traumatic brain injury.

CorTechs Labs (La Jolla, CA, USA) reported that it is renewing and expanding a partnership and distribution agreement with Invivo Corp. (Gainesville, FL, USA;  a subsidiary of Philips Healthcare [Best, The Netherlands]) for NeuroQuant, a software solution for volumetric brain atrophy in the US healthcare market.

NeuroQuant is a crucial part of Invivo’s DynaSuite neuroimaging solution. “We’re pleased to expand our relationship with Invivo. With great expertise and presence in advanced clinical solutions for MRI, Invivo has been a terrific partner and has demonstrated exceptional growth with our NeuroQuant product in the US,” said Guri Stark, CorTechs Labs’ CEO. “We look forward to partnering with Invivo to continue NeuroQuant’s growth momentum and establishing our vision to have NeuroQuant become the standard test for all brain disorders, including Alzheimer’s disease, epilepsy and traumatic brain injury.”

“CorTechs Labs is a pioneer in the area of software for the aid of brain diagnostics and has a tremendous track record of reliability and automation in clinical practices,” stated Tom Tynes, director of strategic business development at Invivo. “We look forward to continuing to offer our DynaSuite neuroimaging solution with NeuroQuant, benefitting from its innovative approach to providing the much needed quantitative brain volumetric information.”

CorTechs Labs develops and markets cutting-edge brain imaging solutions used by neurologists and radiologists in hundreds of clinics and research centers around the world. CorTechs’ cornerstone product, NeuroQuant, is a breakthrough, 510(k)-cleared medical device that makes quantitative analysis of MRI images of the human brain a routine part of clinical practice.

Invivo is a subsidiary of Philips Healthcare (Best, The Netherlands) and develops progressive MRI coils, cutting-edge clinical solutions, and MRI-compatible interventional devices.

Related Links:

CorTechs Labs

SuperSonic Imagine



view channel
Image: The quantitative character of the novel 3D technique on MR scans from a patient with primary liver cancer is demonstrated. Images A and B show the scan of the patient before being treated with chemoembolization. The new 3D technique helped quantify the volume and distribution of viable tumor tissue (shown in red and yellow colors). Images C and D demonstrate MR scans acquired after the treatment. The new 3D method helped the radiologists to quantify the vast central destruction of the tumor after the treatment (the dead tumor is represented by the blue color) (Photo courtesy of Johns Hopkins Medicine).

3D MRI Offers Improved Prediction of Survival After Chemotherapy for Liver Tumors

Researchers are using specialized three-dimensional (3D) magnetic resonance imaging (MRI) scanning technology to accurately measure living and dying liver tumor tissue in order to quickly show whether... Read more


view channel
Image: Siemens Healthcare has launched the HELX Evolution, the newest iteration of its Acuson S range of ultrasound imaging systems (Photo courtesy of Siemens Healthcare).

Ultrasound Imaging System Enhancements Include High Definition Transducers, Sophisticated Elastography, and Tissue Strain Analysis

New features designed for a range of ultrasound systems include enhanced image quality with a large 21.5-inch liquid crystal diode (LCD) monitor, high definition (HD) transducers, optimized contrast agent... Read more

Nuclear medicine

view channel
Image: Sagittal section of brain PET image at four hours after 64CuCl2 injection with disulfiram or D-penicillamine in MD model mice (Photo courtesy of the RIKEN Center for Life Science Technologies).

PET Imaging Used to Assess Effectiveness of Menkes Disease Treatments

Japanese scientists are using positron emission tomography (PET) imaging to visualize the distribution of copper in the body using lab mice. Copper distribution is deregulated in a genetic disorder called... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Software Designed for the Assessment of Orthopedic Implant Fixation and Bone Segment Motion

Model-based roentgen stereophotogrammetric analysis (MBRSA) software has been developed for evaluation of orthopedic implant fixation and bone segment motion. The software is the first to measure the in vivo three-dimensional (3D) position and/or relative motion of metal implants, markers beads, and/or bone segments in... Read more
Copyright © 2000-2014 Globetech Media. All rights reserved.